Thierry Danays.

Guy Meyer, M.D Ed pills en EspaƱa ., Eric Vicaut, M.D., Thierry Danays, M.D., Giancarlo Agnelli, M.D., Cecilia Becattini, M.D., Jan Beyer-Westendorf, M.D., Erich Bluhmki, M.D., Ph.D., Helene Bouvaist, M.D., Benjamin Brenner, M.D., Francis Couturaud, M.D., Ph.D., Claudia Dellas, M.D., Klaus Empen, M.D., Ana Franca, M.D.D., Annette Geibel, M.D., Samuel Z. Goldhaber, M.D., David Jimenez, M.D., Ph.D., Matija Kozak, M.D., Christian Kupatt, M.D., Nils Kucher, M.D., Irene M. Lang, M.D., Mareike Lankeit, M.D., Nicolas Meneveau, M.D., Ph.D., Gerard Pacouret, M.D., Massimiliano Palazzini, M.D., Antoniu Petris, M.D., Ph.D., Piotr Pruszczyk, M.D., Matteo Rugolotto, M.D., Aldo Salvi, M.D., Sebastian Schellong, M.D., Mustapha Sebbane, M.D., Bozena Sobkowicz, M.D., Branislav S.

Breast cancers is a significant medical condition and statistics suggest that one in eight women will develop the disease in her lifetime. The stage at which the tumor is discovered influences a female's chance of survival and annual mammography after the age group of 40 enables physicians to recognize the smallest abnormalities. In fact, when breast malignancy is usually detected early and confined to the breast, the five-year survival rate is 97 %. ‘Breasts cancers caught in the initial stages by mammography will be cured and so are less likely to require chemotherapy or as comprehensive operation,’ said Dr. Plecha, who is also Assistant Professor at Case Western Reserve University School of Medicine.